What causes cgrp
Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.
Last updated: April 4, 2026
Key Facts
- CGRP is a neuropeptide found in the nervous system.
- It is implicated in the pathophysiology of migraine headaches.
- CGRP causes vasodilation of cranial blood vessels.
- Levels of CGRP are elevated during migraine attacks.
- New migraine treatments target the CGRP pathway.
What is Calcitonin Gene-Related Peptide (CGRP)?
Calcitonin gene-related peptide (CGRP) is a neuropeptide, which is a small protein molecule that acts as a messenger in the nervous system. It is widely distributed throughout the body, with significant concentrations found in the brain and peripheral nervous system, particularly within the trigeminovascular system. This system is a network of nerves and blood vessels in the head that is critically involved in the sensation of pain, especially facial pain and headaches.
The Role of CGRP in Migraine Pathophysiology
For many years, theories about migraine focused on blood vessel changes, such as constriction and dilation. However, research over the past few decades has highlighted the central role of CGRP in the development of migraine headaches. It is now understood that CGRP is not merely a bystander but an active participant in the migraine process.
CGRP Release During Migraine Attacks
During a migraine attack, there is a significant release of CGRP from the trigeminal nerve endings that innervate cranial blood vessels. This release is thought to be triggered by various factors that can initiate a migraine, although the precise triggers are still being investigated. Once released, CGRP exerts its effects on surrounding tissues.
Mechanisms of Action of CGRP
CGRP has several key effects that contribute to migraine symptoms:
- Vasodilation: CGRP is a potent vasodilator, meaning it causes blood vessels to widen. In the context of the head, this vasodilation of cranial arteries, such as the meningeal arteries that supply blood to the brain's coverings, is believed to contribute to the throbbing pain characteristic of migraines.
- Neurogenic Inflammation: CGRP can also promote neurogenic inflammation. This involves the release of inflammatory mediators from nerve endings, leading to swelling and increased sensitivity in the tissues around blood vessels. This inflammatory response can further sensitize pain pathways.
- Pain Transmission: CGRP plays a role in transmitting pain signals from the periphery to the central nervous system. It can sensitize neurons in the trigeminal nucleus caudalis, a key relay center for head pain, making them more responsive to stimuli and amplifying the perception of pain.
Evidence Supporting CGRP's Role
A substantial body of evidence supports CGRP's involvement in migraines:
- Elevated Levels: Studies have consistently shown that CGRP levels are significantly elevated in the blood and saliva of individuals during a migraine attack compared to when they are pain-free. These levels return to normal as the headache subsides.
- Pharmacological Effects: Administering CGRP to individuals can trigger migraine-like headaches, especially in those with a history of migraines. Conversely, blocking the action of CGRP can alleviate migraine pain.
- Genetic Studies: While not as prominent as other genetic factors, some research has explored potential genetic links to CGRP or its receptors that might influence migraine susceptibility.
CGRP and Migraine Treatment
The understanding of CGRP's role has revolutionized migraine treatment. Two main classes of drugs have been developed:
1. CGRP Antagonists (Gepants)
These are oral medications that block the CGRP receptor, preventing CGRP from binding and exerting its effects. Gepants can be used both for the acute treatment of migraine attacks and, in some cases, for migraine prevention. Examples include ubrogepant and rimegepant.
2. CGRP Monoclonal Antibodies
These are injectable medications that target either the CGRP molecule itself (preventing it from binding to its receptor) or the CGRP receptor. They are primarily used for migraine prevention and are typically administered monthly or quarterly. Examples include erenumab, fremanezumab, and galcanezumab.
These targeted therapies represent a significant advancement over older migraine medications that often had broader mechanisms of action and more side effects. By specifically targeting the CGRP pathway, these drugs offer a more precise approach to managing migraine pain.
Beyond Migraine: Other Potential Roles of CGRP
While CGRP is most extensively studied for its role in migraine, it also has other physiological functions. It is involved in regulating blood pressure, heart rate, and gastrointestinal motility. It also plays a role in bone metabolism and wound healing. However, its contribution to pain pathways, particularly in the context of headache disorders, remains its most clinically significant and well-researched function.
More What Causes in Daily Life
Also in Daily Life
More "What Causes" Questions
Trending on WhatAnswers
Browse by Topic
Browse by Question Type
Sources
Missing an answer?
Suggest a question and we'll generate an answer for it.